Elevated Lp(a): Guidance for Identifying and Managing Patients

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know2022 · 42 citations
2. 2Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease2022 · 597 citations
3. 3Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial2020 · 222 citations
4. 4Association of<i>LPA</i>Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies2018 · 692 citations
5. 5Pharmacokinetics, Pharmacodynamics, and Tolerability of Olpasiran in Healthy Japanese and Non-Japanese Participants: Results from a Phase I, Single-dose, Open-label Study2022 · 32 citations